Renal blood flow was measured by the indicator-dilution technic in 17 patients with shock related to sepsis, myocardial infarction, pulmonary embolism, or pancreatitis. Renal blood flow averaged 225 ml/min/kidney, the renal plasma transit time was prolonged to an average of nearly three times normal, and the renal fraction of cardiac output was reduced to an average of 10 
leading to a reduction in the renal fraction of cardiac output. Other investigators, however, have noted no significant change or even a decrease in renal resistance during experimental shock. [5] [6] [7] Renal hemodynamics in shock in man have not been fully assessed because of the technical difficulties encountered in measuring renal blood flow in acutely ill patients with reduced urinary flow. Decreased para-aminohippurate clearance in patients with hemorrhagic and traumatic shock was -reported by Lauson The presence and intensity of renal vasoconstriction in shock may have an important bearing on the selection of therapy. Since prolonged renal hypoperfusion and oliguria probably contribute to the development of acute tubular necrosis,10 one of the important goals of therapy in shock has been to increase renal blood flow. In the presence of active renal vasoconstriction successful treatment must relax renal arteriolar constriction. On the other hand, if the fall in blood flow occurs passively because of a fall in arterial pressure, increasing perfusion pressure alone might restore more normal renal flow.
In the present study an indicator-dilution technic has been utilized to assess renal blood flow at the bedsides of patients with nonhemorrhagic and nontraumatic shock due to a variety of causes. This method has made it possible to quantitate renal hemodynamic changes during the course of treatment of clinical shock. The severity of renal vasoconstriction has been evaluated, and the renal vascular response to infusion of vasoconstrictor and vasodilator drugs and to rapid infusion of dextran has been assessed.
Methods
Studies were performed on 17 male patients with the clinical manifestations of shock. Informed consent for the procedure was obtained from the patient or his family. Shock was diagnosed by a fall in auscultatory blood pressure associated with signs of deficient peripheral blood flow, as previously described." Intra-arterial Significance of differences between patients and normal subjects: *P < 0.01. Abbreviations: MAP = mean arterial pressure; RVP = renal venous pressure; RBF cardiac output; SVR = systemic vascular resistance; RR indocyanine-green dye. (Table 1) In 11 patients sepsis was a major factor in the etiology of the shock; one of these 11 had both shock and myocardial infarction. Three patients had suffered an acute myocardial infarction only; two developed shock following acute pulmonary embolism; and one patient had shock as a complication of acute pancreatitis. The interval between the onset of shock and the hemodynamic measurements varied from 1 to 36 hours. Four of the patients survived, and in three others the shock was corrected although the patients succumbed some weeks later from other complications of their underlying disease including infection, malignancy, and heart failure. The other 10 subjects died within the ensuing week although the signs of shock were at least temporarily corrected in five of them.
The blood urea nitrogen was normal or moderately elevated at the time of study in 12 of the patients but markedly elevated in five others, including two patients with preexisting renal insufficiency. BUN rose progressively after the episode of shock in four patients, in three of whom postmortem examination confirmed the diagnosis of tubular necrosis. Changes in renal blood flow (RBF) even in the patient who did not exhibit an increase in calculated blood flow, with the average for the group decreasing from 13.5 to 8.9 sec. Systemic blood pressure was not altered by acetylcholine and was reduced by only 2 to 4 mm Hg after infusion of hydralazine.
Discussion
Several fectors tend to make the patients with shock ijLcluded in this study somewhat atypical. Although all the patients were critically ill, their conadition was stable enough to allow the catheterization procedure to be accomplished and, except in one patient, for vasoactive drug therapy to be temporarily withheld. Thus, individuals with profound shock and a rapidly deteriorating circulation were necessarily excluded from study. Furthermore, the cardiac output tended to be somewhat higher and the total systemic vascular resistance lower in this group of patients when compared to previous groups of patients studied in this laboratory.14 This difference could in part be attributed to the high incidence in the present series of septic shock, which may sometimes be associated Circulation, Volume XLII, November 1970 with a normal or high cardiac index and a low peripheral resistance.9 In addition, however, the data from several patients with very low cardiac outputs could not be included in this report because renal dye curves were so prolonged and distorted that accurate analysis of curves was not possible. Radiopaque dye injected into the renal artery in these patients was observed to oscillate in the large arteries with each cardiac cycle and to advance extremely slowly through the kidney. Thus, the indicator-dilution technic is invalid in the presence of such severe reduction in renal blood flow, either because mixing of the dye is inadequate or because renal venous sampling becomes contaminated with vena caval blood under these circumstances. It must be recognized, therefore, that the data from the patients included probably underestimate the severity of the deficiency in renal perfusion which may occur in shock.
Renal blood flow calculated from the dye curves was below the usually accepted normal range during the control period in all the patients studied and was less than 300 ml/min/kidney in 12 of the 16 patients. The curves were usually only slightly irregular in contour and displayed the expected exponential washout. The mean transit time of indocyanine green was, however, considerably prolonged. The prolonged dye transit through the kidney could signify slowing of flow through the cortical bed or redistribution of blood flow from the usually rapidly circulating superficial cortical bed to the more slowly circulating deeper cortical or medullary areas. 15 In either situation, the dye curves would give an accurate measurement of total renal blood flow only if all the injected dye traversed the kidney and appeared in renal venous blood during inscription of the dye curve. Although some dye undoubtedly enters the inner medullary circulation, which has a transit time considerably longer than the recorded curves,16 studies of normal and hypertensive subjects indicate that the amount of dye "lost" probably is so small that the dye curve yields an accurate value for flow.13 17 However, renal vasoconstriction may increase the fraction of injected dye which is not recovered in the recorded curve.'8 Carriere's group'9 utilizing radioisotope clearance methods and radioautography, suggested that cortical flow is markedly reduced in shock and that medullary blood flow may be preserved. Aukland and Wolgast,20 however, measured the local medullary clearance of hydrogen gas and concluded that medullary blood flow fell proportionately with cortical blood flow during hemorrhage. If in the patients with shock in the present series a significant percentage of the injected dye entered renal vascular channels with transit times longer than the recorded dye curves, the calculated values for renal blood flow would be falsely high. This inaccuracy again would lead to an underestimation of the severity of the renal hypoperfusion.
The low renal blood flow, demonstrated in these patients with shock even when the cardiac output was normal, indicates that the kidney does not share in the abnormally reduced systemic vascular resistance which may sometimes be associated with hypotensive states. Nonetheless, the striking correlation noted between renal resistance and nonrenal systemic resistance suggests that renal vasoconstriction in shock is a manifestation of a more generalized vasoconstrictor process. Thus, in the absence of an increase in systemic vascular resistance the kidney circulation is also less vasoconstricted. If the renal vasoconstriction results from sympathetic nervous system discharge, these observations imply that low-resistance shock may be characterized by a less intense adrenergic response than is observed in individuals with high calculated systemic vascular resistance. The previous observation that the cutaneous bed appears less constricted in low-resistance shock is consistent with this formulation.14 From the present data it is difficult to quantitate the severity of renal vasoconstriction which may occur in shock. In more than half of the patients studied renal vascular resistance was not above the normal range. Even in these subjects, however, the renal fraction of cardiac output was reduced and the renal bed, therefore, was relatively more constricted than the rest of the systemic circulation. In this small series the level of renal resistance was not significantly related to the patient's age, the cause of the shock, or the level of arterial pressure. In the one patient in this series with very low cardiac output and high systemic vascular resistance, renal resistance was markedly increased, and the renal fraction was less than 10%. Thus, it is likely that had the series included more patients with classic cardiogenic or hypovolemic shock, renal vascular resistance would have been elevated. Despite the variation in the degree of renal vasoconstriction implied by renal resistance measurements, the present data clearly indicate that clinical shock is characterized by a preferential diversion of blood flow away from the renal bed to other more critical or more dilated vascular beds. Although some previous experimental studies have failed to reveal any evidence for renal vasoconstriction soon after hemorrhage,5-7 during prolonged observations the renal resistance usually increases.20 22 Since most of the flow measurements in the present study were made several hours after the first clinical signs of shock were detected, the patients were probably in a stage similar to the later Circulation, Voluame XLll, phases of experimental shock characterized by a reduced renal fraction of cardiac output.
Renal vasoconstriction could be attributed to neurogenic or humoral influences. Since renal nerve stimulation reduces renal blood flow23 and renal denervation provides considerable protection from renal vasoconstriction in experimental shock,24 it is likely that reflex activation of the sympathetic nervous system is an important factor in the increase in renal vascular resistance. That this renal vasoconstriction was promptly moderated in many patients in this series by rapid plasma volume expansion with dextran implies that inadequate systemic venous return was an important factor in the initiation or perpetuation of the sympathetic discharge to the kidney. The salutary effect of dextran infusion in patients with shock in the absence of evidence of external fluid losses has previously been observed in this laboratory.25 The shortening of the intrarenal circulation time after volume expansion further attests to relaxation of renal vasoconstriction, resulting in more rapid flow through cortical channels or re-distribution of blood flow toward the outer cortex. Although some authors have recommended the use of alpha-adrenergic blocking agents to inhibit reflex vasoconstriction in shock,26 the sharp fall in systemic and renal vascular resistance after dextran infusion in these patients indicates that rapid plasma volume expansion may be an effective and perhaps safer way to inhibit acutely adrenergic overactivity in shock.
Isoproterenol administration also was associated with a fall in renal vascular resistance, an increase in renal blood flow, and a shortening of renal mean transit time; however, the renal fraction usually was unchanged or decreased. In previous studies isoproterenol has also been noted to decrease renal vascular resistance and reduce the renal fraction.27 28 Thus, the renal vasodilation resulting from beta-adrenergic stimulation usually is less prominent than the vasodilation occurring in other vascular beds because the renal vascular bed apparently is not richly endowed with beta-adrenergic receptors.
Circulation, Volume XLII, November 1970 Dopamine, which has been shown to have a specific renal vasodilator effect as well as alpha and beta-adrenergic stimulating properties,29 also increased renal blood flow in one patient.
The vasoconstrictor drugs consistently increased renal resistance, but the effect on renal blood flow was variable. Although norepinephrine and metaraminol have direct renal vasoconstrictor effects,30 renal blood flow sometimes has been shown to increase during their infusion.31-33 Corday and Williams33 noted an increase in renal blood flow from pre-infusion levels when the blood pressure was allowed to stabilize at normotensive levels. The net effect of norepinephrine, metaraminol, and angiotensin on the renal circulation in shock probably depends on an interplay between the effects of direct vasoconstriction and of decreased sympathetic discharge to the kidney which might follow restoration of normal arterial pressure. Renal transit time was prolonged by the drugs in some patients, consistent with the previous demonstration of slowed intrarenal circulation during infusion of norepinephrine in the normal dog.34 When the control transit time was very long, however, norepinephrine infusion resulted in a paradoxical shortening of intrarenal circulation time.
Despite plasma volume expansion or systemic administration of a variety of vasoactive agents in these patients, renal hypoperfusion and prolonged renal mean transit time usually persisted. Renal vasoconstriction also has been noted to persist after reinfusion in experimental hemorrhagic shock. 35 If restoration of a nearly normal blood flow is important in maintaining renal function and the structural integrity of the kidney in shock, it is clear that these modes of therapy are not ideal. The prompt rise of renal blood flow to normal or high levels during renal arterial infusion of acetylcholine or hydralazine confirms that functional vasoconstriction persists during treatment of shock. If the renal vasodilation continued during prolonged administration, such local renal infusion of vasodilator drugs might be a rational approach to the management of renal hypoperfusion in selected cases; however, this treatment certainly would not be practical on a large scale. Thus, the search is justified for drugs which by systemic administration might have a specific and potent renal vasodilating effect without at the same time further reducing arterial pressure. Dopamine may exert such an effect, but further clinical study is needed to ascertain whether this pharmacologic property is therapeutically useful. We have previously described the unique effects in man of phenylalanine lysine vasopressin, which raises arterial pressure by peripheral vasoconstriction while exerting a renal vasodilator effect. 36 It is likely that other drugs with such specificity of action might be found.
